ArticleOncotarget2020

Response of a chemo-resistant triple-negative breast cancer patient to a combination of p62-encoding plasmid, Elenagen, and CMF chemotherapy.

Dmitry M Ponomarenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.